Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rousseau A et al. – Identification of specific genomic imbalances at a given tumor location suggests that ependymomas from different central nervous system (CNS) regions represent genetically distinct diseases. Detecting genomic alterations associated with aggressive biological behavior may help stratify patients in high– and low–risk disease.


Related Articles

Cervical Ependymoma in a Male Adolescent With Neck and Back Pain
Journal of Manipulative and Physiological Therapeutics, 10/19/09    Relevance Score: 83%

Long-Term Surgical Outcomes for Myxopapillary Ependymomas of the Cauda Equina
Spine, 10/09/09    Relevance Score: 83%

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial
European Journal of Cancer, 10/13/09    Relevance Score: 82%

Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma
Brain Pathology, 10/02/09    Relevance Score: 82%

Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
Pediatric Blood & Cancer, 10/23/09    Relevance Score: 80%

Today in Neurologic Oncology...keeping you current

Birth weight and risk of neuroblastoma: a meta-analysis
International Journal of Epidemiology, 03/19/10

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
British Journal of Cancer, 03/19/10

Pharmacological treatment of depression in patients with a primary brain tumour
Cochrane Reviews, 03/19/10


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address